Methyl 5-fluoro-6-methoxy-1H-indole-2-carboxylate, 95.0%, 100mg

6,7-DIMETHYL-7H-PYRROLO[2,3-D]PYRIMIDINE-4-CARBOXYLIC ACID, 95.0%, 250mg

6-Bromoisoquinoline, 98.0%, 10g

5-CHLORO-2-(4-FLUOROPHENYL)PYRIMIDINE-4-CARBOXYLIC ACID, 95%, 250mg

Microliter syringe GASTIGHT® series 1700 Point type 3, 250 µl, 1725 RNR, 1 piece

Benzo[c][1,2,5]oxadiazol-5-amine, 98%, 5g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-aminopentanoic acid hydrochloride, 95.0%, 10g

Methylcyclohexane, min. 99%, for synthesis, 25 l, whitbl.

5-Chloro-[1,1'-biphenyl]-2-amine, 95.0%, 10g

1-Bromo-3,5-diphenoxybenzene, 96%, 5g

9H-Pyrido[3,4-b]indole, 95.0%, 5g

2-Hydroxy-4-pyridinecarboxylic acid, 97.00%, 25g

3-iso-Propoxybenzaldehyde, 95.0%, 250mg